Pregabalin Versus Levetiracetam In Partial Seizures
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This study will compare pregabalin and levetiracetam in patients with partial seizures. It
will also evaluate the safety and tolerability of pregabalin and levetiracetam in these
patients.
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.